Solid Tumors Harboring NTRK Fusion Active Not Recruiting Phase 2 Trials for Larotrectinib (DB14723)

Also known as: Solid Tumors Harbouring NTRK Fusion / Solid Tumors Habouring NTRK Fusion

IndicationStatusPhase
DBCOND0117977 (Solid Tumors Harboring NTRK Fusion)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02576431A Study to Test the Effect of the Drug Larotrectinib in Adults and Children With NTRK-fusion Positive Solid TumorsTreatment